| Date |
Note |
| 27/02/2025 |
Addition of ustekinumab and adalimumab formulations and etrasimod (SMC2655). Removal of ozanimod (SMC2478), tofacitinib (SMC2122) and golimumab NICE TA329 (SMC946/13), ERFC December 24. |
| 20/11/2023 |
Addition of Ozanimod SMC2478 ERFC August 2023. |
| 31/08/2023 |
Removed 'Remsima 120mg/1ml solution for injection pre-filled syringes' as product discontinued. |
| 04/04/2023 |
Addition of Upadacitinib SMC2510, ERFC Feb23. Update to prescribing notes and pathway title, ERWG March 23. |
| 27/10/2022 |
Filgotinib (Jyseleca) added, ERFC May 22. |
| 15/12/2021 |
East Region Formulary content agreed. |
